Clinical Trials Directory

Trials / Completed

CompletedNCT05951010

Cerebellar Transcranial Direct Current Stimulation in Spinocerebellar Ataxia 38

Comparison of Two Therapeutic Approaches of Cerebellar Transcranial Direct Current Stimulation in a Sardinian Family Affected by Spinocerebellar Ataxia 38: a Clinical and Computerized 3D Gait Analysis Study.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
7 (actual)
Sponsor
University of Cagliari · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Spinocerebellar ataxia 38 (SCA 38) is a very rare autosomal dominant inherited disorder caused by a mutation in ELOV5 gene, specifically expressed in cerebellar Purkinje cells, encoding an enzyme involved in the synthesis of fatty acids. The present study aimed to assess the effect of cerebellar anodal transcranial direct current stimulation (tDCS) administered employing deltoid (CD-tDCS) and spinal (CS-tDCS) cathodal montage. Clinical evaluation was performed at baseline (T0), after 15 sessions of tDCS (T1) and after one month of follow-up (T2).

Conditions

Interventions

TypeNameDescription
DEVICETranscranial Direct Current StimulationAnodal stimulation was delivered by a battery-driven stimulator (Neuroelectrics, Barcellona, Spain) through a pair of saline-soaked surface sponge electrodes (7 x 5 cm2) producing a constant current of 2 mA for 20 min. The anode was placed 2 cm under the inion and the cathode was placed over the right deltoid muscle (CD-tDCS) or the spinal lumbar enlargement (2 cm under T11) as described by Benussi et al. (CS-tDCS). An electroconductive gel was applied to the electrodes to reduce contact impedance and the electrodes were held in place using elastic gauzes.

Timeline

Start date
2022-11-01
Primary completion
2023-06-01
Completion
2023-06-01
First posted
2023-07-18
Last updated
2023-07-18

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05951010. Inclusion in this directory is not an endorsement.